Literature DB >> 18544012

Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.

Pamela S Hair1, Michael D Ward, O John Semmes, Timothy J Foster, Kenji M Cunnion.   

Abstract

The human complement system plays an important role in the control of Staphylococcus aureus infection. For instance, we previously demonstrated that the central complement component deposited on the organism's surface, C3b, can be cleaved by the host complement control protein, factor I, resulting in diminished phagocytosis of S. aureus. In the present study, we have identified clumping factor A (ClfA) from cell wall proteins of S. aureus as a specific protein bound by factor I. Recombinant ClfA (rClfA) containing the full-length A region (peptides 40-559) also bound factor I. We identified an 50-kDa fragment of ClfA that is shed by S. aureus into growth medium. The shed ClfA fragment was derived from the A region of ClfA and bound factor I. rClfA and the shed ClfA fragment increased factor I cleavage of C3b into inactive C3b. Our findings describe a new S. aureus mechanism for modification of host complement activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544012     DOI: 10.1086/588825

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

3.  New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.

Authors:  Walid F Elkhatib; Pamela S Hair; Julius O Nyalwidhe; Kenji M Cunnion
Journal:  J Med Microbiol       Date:  2015-04       Impact factor: 2.472

Review 4.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.

Authors:  Timothy J Foster; Joan A Geoghegan; Vannakambadi K Ganesh; Magnus Höök
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

5.  Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen.

Authors:  Joan A Geoghegan; Vannakambadi K Ganesh; Emanuel Smeds; Xiaowen Liang; Magnus Höök; Timothy J Foster
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  The iron-regulated surface determinant B (IsdB) protein from Staphylococcus aureus acts as a receptor for the host protein vitronectin.

Authors:  Giampiero Pietrocola; Angelica Pellegrini; Mariangela J Alfeo; Loredana Marchese; Timothy J Foster; Pietro Speziale
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

7.  The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus.

Authors:  Emma Jane Smith; Livia Visai; Steven W Kerrigan; Pietro Speziale; Timothy J Foster
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

8.  Sortases, Surface Proteins, and Their Roles in Staphylococcus aureus Disease and Vaccine Development.

Authors:  Olaf Schneewind; Dominique Missiakas
Journal:  Microbiol Spectr       Date:  2019-01

9.  Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.

Authors:  Pamela S Hair; Caitlin K Foley; Neel K Krishna; Julius O Nyalwidhe; Joan A Geoghegan; Timothy J Foster; Kenji M Cunnion
Journal:  Results Immunol       Date:  2013-11-09

Review 10.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.